ViaNautis

PITCH

ViaNautis is exploiting its proprietary technology, polyNaut®, a nanovesicle platform using advanced polymer materials and machine learning, to direct nucleic acid therapeutics to the specific site of action with unparalleled precision. We are focused on delivery to the brain, CNS, lung, and other hard to reach areas of the body.

Based in

Cambridge

Created in

> Website

LATEST INVESTMENT

#Biotech 11.2023

£20.34M

4BIO Capital, BGF, UCB Ventures, Cystic Fibrosis Foundation, Eli Lilly and Company, Origin Capital, Meltwind & O2H